https://charts.traderzeitung.de/phases/US1421521071
string(1501) "{"isin":"US1421521071","name":"Caris Life Sciences Inc","stock_id_xnas":112362998,"stock_id_xnys":null,"generated_at":"2026-08-21 04:23:00","days":[{"date":"2026-08-18","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":21.55,"close_at":"2026-08-18 13:46:00","complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":20.97,"close_at":"2026-08-18 21:59:00","complete":true,"perf_pct":-2.6914},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":21.19,"close_at":"2026-08-19 00:26:00","complete":true,"perf_pct":1.0491}]},{"date":"2026-08-19","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":22,"close_at":"2026-08-19 15:28:00","complete":true,"perf_pct":3.8226},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":22.755,"close_at":"2026-08-19 21:59:00","complete":true,"perf_pct":3.4318},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":22.9,"close_at":"2026-08-19 23:46:00","complete":true,"perf_pct":0.6372}]},{"date":"2026-08-20","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":22.89,"close_at":"2026-08-20 10:03:00","complete":true,"perf_pct":-0.0437},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":24.575,"close_at":"2026-08-20 21:59:00","complete":true,"perf_pct":7.3613},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"
Caris Life Sciences Aktie News & Nachrichten
Trading-Room

Caris Life Sciences Aktie News & Nachrichten

[WKN: A41A14 | Symbol: CAI]
Realtimekurs
   
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Caris Life Sciences

TOP-5-Kursziele der Analysten am 13.04.26

Credo Technology [KYG254571055] Jefferies startet Berichterstattung mit "Buy" und Kursziel 175 USD...

Caris Life Sciences: Hohe Nachfrage nach Dienstleistungen im Bereich der molekularen Profilerstellung ermöglicht Profitabilität im 4. Quartal - Experten bestätigen Kaufempfehlungen

Caris Life Sciences Inc. (CAI) ist ein zentraler Akteur im Wandel von der standardisierten "One-Size-Fits-All"-Behandlung...

  • ‹
  • 1
  • ›
Caris Life Sciences Nachrichtenticker öffnen
MT Newswires 05.08.2026 22:35 Uhr

-- Earnings Flash (CAI) Caris Life Sciences, Inc. Meldet Q2-Umsatz von 263,7 Mio. $, ggü. FactSet-Schätzung von 238,1 Mio. $

04:21 PM EDT, 05.08.2026 (MT Newswires) -- http://www.mtnewswires.com Copyright © 2026 MT Newswires. All rights reserved. MT Newswires does not provid

MT Newswires 13.07.2026 17:37 Uhr

BofA passt Kursziel für Caris Life Sciences von $28 auf $23 an

11:36 AM EDT, 07/13/2026 (MT Newswires) -- Caris Life Sciences, Inc. (CAI) hat eine durchschnittliche Bewertung von "overweight" und ein mittleres Kur